EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia



Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia



Clinical and Experimental Medicine 6(1): 45-47



Very satisfactory results have been obtained with the treatment of sickle cell anaemia with hydroxyurea (HU), an antineoplastic drug. This is because it significantly increases the levels of foetal haemoglobin. Nevertheless, inadequate dosages or prolonged treatment with this pharmaceutical can provoke cytotoxicity or genotoxicity, increasing the risk of neoplasia.

(PDF emailed within 0-6 h: $19.90)

Accession: 012614455

Download citation: RISBibTeXText

PMID: 16550344

DOI: 10.1007/s10238-006-0093-8



Related references

The prognostic impact of CD7 expression of leukaemic blasts in de novo intermediate cytogenetic risk acute myeloid leukaemia. Pathology 48 Suppl 1: S99-S99, 2016

Effect of small interfering RNA targeting wild-type FLT3 in acute myeloid leukaemia cells in vitro and in vivo. Journal of International Medical Research 39(5): 1661-1674, 2012

Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia. Leukemia 6(8): 786-790, 1992

Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα. Plos One 7(6): E38104-E38104, 2012

Silencing of gene expression in cultured cells using small interfering RNAs. Current Protocols in Cell Biology Chapter 27: Unit 27.1.1-28, 2010

MDR-1 gene expression in leukaemic and normal hematopoietic cells in acute leukaemia patients. British Journal of Haematology 93(SUPPL 2): 354, 1996

Rapid downregulation of cathepsin G mRNA expression acute promyelocytic leukaemia cells and human myeloid leukaemic cell lines in response to retinoic acid. British Journal of Haematology 87(SUPPL 1): 203, 1994

Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia. British Journal of Cancer 66(2): 266-272, 1992

Effects of small interfering RNAs targeting Fascin on gene expression in oral cancer cells. Journal of Oral Pathology & Medicine 38(9): 722-730, 2009

Stimulation and reactivity of leukaemic cells in acute myeloid leukaemia. Acta Haematologica 51(3): 129-139, 1974

Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs. Biochemical Pharmacology 70(10): 1424-1430, 2005

The anti-leukaemic activity of novel synthetic naphthoquinones against acute myeloid leukaemia: induction of cell death via the triggering of multiple signalling pathways. British Journal of Haematology 147(4): 459-470, 2010

Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small interfering RNAs. Methods in Molecular Biology 292: 401-420, 2004

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia. British Journal of Haematology 126(4): 508-511, 2004

Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis. Cell Biology International 32(9): 1081-1090, 2008